|
Match
|
Document |
Document Title |
|
|
7575928 |
Genes for diagnosing colorectal cancer
This invention relates to provide the genes for diagnosing colorectal cancer, the gene sequences searching comprise the steps of: (1) deriving epithelium cells from normal intestines, polypus of...
|
|
|
7575926 |
Method of identification of compounds effective against suppressed cancer cells
A method for identifying compounds capable of targeting suppressed cancer cells, the method including the steps of comparing the response to a test compound of cancer cells grown on a suppressing...
|
|
|
7575749 |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate...
|
|
|
7572923 |
Indirubin derivatives having anticancer property against human cancer cell line
The present invention relates to an indirubin derivative having anticancer property by inhibiting cell proliferation as to human cancer cell line. More particularly, this invention provides the...
|
|
|
7572887 |
Gene expressed in prostate cancer, methods and use thereof
A polypeptide is disclosed that is specifically detected in the cells of the prostate, termed Splice Variant-Novel Gene Expressed in Prostate (SV-NGEP). Polynucleotides encoding SV-NGEP are also...
|
|
|
7572816 |
Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
The present invention is directed to compounds having the structure wherein R 1 , R 2 , R 3 , R 4 , R 5 and m are as defined herein. The compounds of this invention are novel therapeutic agents...
|
|
|
7572814 |
3,5-dibenzoyl-4-phenyl-piperidine anti-cancer compounds
Certain 3,5-dibenzoyl-4-phenyl-piperidine compounds and salts thereof are provided herein. The compounds and salts may be useful in causing mitotic arrest and cell death. Also provided herein are...
|
|
|
7572448 |
Combined cancer treatment methods using selected antibodies to aminophospholipids
Disclosed are surprising discoveries concerning the role of anionic phospholipids and aminophospholipids in tumor vasculature and in viral entry and spread, and compositions and methods for...
|
|
|
7570063 |
Space-time microwave imaging for cancer detection
Microwave imaging via space-time beamforming is carried out by transmitting microwave signals from multiple antenna locations into an individual to be examined and receiving the backscattered...
|
|
|
7569711 |
Enone cancer therapeutics
Described herein are new enone derivatives and conjugates. Additionally, methods for synthesizing these new enones are also disclosed. These compounds can be employed in cancer therapy.
|
|
|
7569662 |
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
Novel markers for lung cancer that are both sensitive and accurate. These markers are overexpressed in lung cancer specifically, as opposed to normal lung tissue. The measurement of these markers,...
|
|
|
7569554 |
Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents
The invention relates to the therapeutic use of immunostimulatory oligonucleotides and/or immunomers in combination with chemotherapeutic agents to provide a synergistic therapeutic effect.
|
|
|
7569551 |
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
Administration of antisense oligodeoxynucleotides (ODN) targeted against the testosterone-repressed prostate message-2 (TRPM-2) gene can reduce the amount of TRPM-2 in renal cell cancer (RCC) cells...
|
|
|
7569356 |
Diagnosis and therapy of cancer using SGP28-related molecules
The present invention relates to methods and compositions for the diagnosis and therapy of prostate cancer which utilize isolated polynucleotides corresponding to the human SGP28 gene, proteins...
|
|
|
7569350 |
Methods for selecting cancer vaccine therapies using extracellular DNA
This invention relates to detection of specific extracellular nucleic acid in plasma or serum fractions of human or animal blood associated with neoplastic or proliferative disease. Specifically,...
|
|
|
7569345 |
Gene expression markers for breast cancer prognosis
The present invention provides gene sets the expression of which is important in the diagnosis and/or prognosis of breast cancer.
|
|
|
7569234 |
Herb composition for treating lung cancer and preparation method thereof
The present invention provides a composition for treating cancers, which comprises (a) pharmaceutically acceptable carriers and (b) an effective amount of an aqueous or aqueous organic solvent...
|
|
|
7566542 |
Use of protein ASC as a marker for breast cancer
The present invention relates to the diagnosis of breast cancer. It discloses the use of protein ASC in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a...
|
|
|
7566452 |
Cancer treatment with endothelin receptor antagonists
The present invention relates to therapeutic protocols and pharmaceutical compositions designed to treat and prevent cancer. More specifically, the present invention relates to a novel method of...
|
|
|
7563880 |
Compositions and methods for the therapy and diagnosis of breast cancer
Compositions and methods for the therapy and diagnosis of cancer, particularly breast cancer, are disclosed. Illustrative compositions comprise one or more breast tumor polypeptides, immunogenic...
|
|
|
7563570 |
Method of determining a chemotherapeutic regimen for non small cell lung cancer based on BRCA1 expression
The present invention relates to a screening method for classifying patients and for selecting an effective chemotherapy for the treatment of a patient suffering from non-small-cell lung cancer...
|
|
|
7563448 |
Modified vaccinia ankara expressing P53 in cancer immunotherapy
Mutations to the tumor suppressor protein p53 have been observed in 40-60% of all human cancers. These mutations are often associated with high nuclear and cytoplasmic concentrations of p53. Since...
|
|
|
7563446 |
Methods and compositions for inducing autoimmunity in the treatment of cancers
Disclosed are methods and compositions for the prevention and treatment of cancers using lipid-carrier protein conjugate compositions for generating lipid-specific immune responses in an animal....
|
|
|
7563444 |
Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer
A novel gene (designated 213P1F11) and its encoded protein, and variants thereof, are described wherein 213P1F11 exhibits tissue specific expression in normal adult tissue, and is aberrantly...
|
|
|
7563442 |
Antibodies to CD40 and methods of treating cancer and enhancing immune responses
The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to CD40, preferably human CD40, and that function as CD40 agonists. The invention also...
|
|
|
RE40862 |
Gossypolone for the treatment of cancer
A method for treating cancer in a human, which comprises administering to the human subject an anti-cancer effective amount of a compound selected from gossypol, gossypol acetic acid, gossypolone,...
|
|
|
7560531 |
Cln101 antibody compositions and methods of use alone and in combination with prostate specific antigen and other cancer markers
This invention relates to a method for assessing risk of prostate and/or ovarian cancer. Specifically, in one embodiment it relates to utilizing both Cln101 and Prostate Specific Antigen (PSA) in...
|
|
|
7560263 |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
The present invention is directed to phenylalanine ammonia-lyase (PAL) variants produced by prokaryotes, wherein such prokaryotic PAL variant has a greater phenylalanine-converting activity and/or...
|
|
|
7560095 |
Cancer specific monoclonal antibodies
Novel monoclonal antibodies and binding fragments thereof specific to human breast cancer, lung cancer, colon cancer and other cancers. The monoclonal antibody does not bind to the cell surface of...
|
|
|
7557215 |
Anthraquinone compounds as anti cancer compounds
Anthraquinone compounds of the general formula (I) or a salt thereof (Formula I) in which R 1 to R 4 are each selected from the group consisting of H, C 1-4 alkyl, X 1 , —NHR 0 N (R 5 ) 2 in...
|
|
|
7557204 |
CUDR as biomarker for cancer progression and therapeutic response
Disclosed is a novel human gene designated CUDR. Provides is also a CUDR gene as a biomarker in the diagnosis of human cancers and a cancer therapy.
|
|
|
7557129 |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
This invention relates to novel diaryl ureas, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and angiogenesis...
|
|
|
7557090 |
Anthracycline antibiotics and methods of treating cancer using the same
The present invention discloses new and novel substituted anthracyclines with modified alkyl-aromatic ring substitutions on the C-3′ of the sugar moiety or modified or unmodified alkyl-aromatic...
|
|
|
7556929 |
Compositions and methods for screening anti-cancer agents in yeast
Methods and kits for identifying novel anti-tumor agents are provided.
|
|
|
7556602 |
Breast cancer screening with adjunctive ultrasound mammography
Ultrasound mammography in which an automated transducer scans the patient's breast to generate many images of thin slices that are processed into few images of thick slices that can be displayed...
|
|
|
RE40839 |
Taxol treatment of cancer
The present invention is a method of treatment for a patient with cancer. In particular, it is a method of treating patients having lymphomas and breast cancer using the microtubule agent,...
|
|
|
7553948 |
Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
Novel markers for ovarian cancer that are both sensitive and accurate. These markers are overexpressed and/or differentially expressed in ovarian cancer specifically, as opposed to normal ovarian...
|
|
|
7553859 |
Macrocycles for the treatment of cancer
The present invention relates to new Macro-cycles of Formula (I), and their use for the treatment of cancer.
|
|
|
7550580 |
Compositions and methods for treatment of prostate and other cancers
Therapeutic agents which target heat shock protein (hsp) 27 in vivo are used to provide treatment to individuals, particularly human individuals, suffering from prostate cancer and other cancers...
|
|
|
7550496 |
Compositions and methods for treating cancer
Hypoxia-activated prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.
|
|
|
7550450 |
Prostate cancer treatment
The instant invention provides potent antiandrogen compounds, such as 3β-acetoxyandrost-1,5-diene-17-ethylene ketal and 3β-hydroxyandrost-1,5-diene-17-ethylene ketal, and methods for their use in...
|
|
|
7550262 |
PTPN11 (SHP-2) mutations and cancer
Diagnostic and therapeutic applications for certain types of cancer and precancerous conditions, including those deriving from hematologic cells, are described. Of particular interest are those...
|
|
|
7550160 |
Composition for treating cancer cells and preparation method for the same
A composition for treating cancer cells and a preparation method therefor are provided. The novel flavonoid compounds are obtained from natural plants, and more particularly the compounds have a...
|
|
|
7547691 |
[4-(Benzo[B]thiophen-2-yl) Pyrimidin-2-yl]-amine derivatives as IKK-beta inhibitors for the treatment of cancer and inflammatory diseases
The present invention provides compounds of Formula I: useful in the treatment of cancer and inflammatory diseases.
|
|
|
7547673 |
Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production
The present invention relates to methods of treating a cancerous tumor using selective inhibitors of ATP production. The present invention also relates to pharmaceutical preparations comprising...
|
|
|
7547455 |
Cancer and inflammatory disorder treatment
Disclosed are extracts, compositions, and methods for treating cancer and inflammatory disorders. Also disclosed are methods for preparing extracts or compounds for treating the disorders.
|
|
|
7547441 |
PAI-2 conjugates for the treatment and imaging of cancer
A method is described for detecting, visualizing, or treating cells, particularly cancerous cells, that express a uPA/uPAR complex. The method employs a PAI-2 conjugate molecule that comprises...
|
|
|
7544476 |
Identifying cancers sensitive to treatment with inhibitors of notch signaling
The disclosure provides a method for identifying cancer tissue sensitive to treatment with an inhibitor of Notch receptor activation. The method comprises determining the level of HeyL gene...
|
|
|
7541437 |
Breast cancer resistance protein (BCRP) and the DNA which encode it
The Breast Cancer Resistance Protein is described, as well as the cDNA encoding said protein. This protein has been found to confer resistance to cancer chemotherapeutic drugs.
|
|
|
7541196 |
Planar optical waveguide based sandwich assay sensors and processes for the detection of biological targets including early detection of cancers
An assay element is described including recognition ligands adapted for binding to carcinoembryonic antigen (CEA) bound to a film on a single mode planar optical waveguide, the film from the group...
|